Marine drugs

Marine drugsNathalie Bourgougnon is the guest editor of this special issue on The journal Marine drugs : "Marine Antiviral Agent".

Many discoveries in the marine environment

During the past few decades there has been an ever increasing number of novel compounds discovered in the marine environment. This is exemplified by the robust preclinical and clinical pipeline that currently exists for marine natural products. Marine Drugs is inviting contributions on new advances in marine biotechnology, pharmacology, chemical ecology, synthetic biology, and genomics approaches related to the discovery of therapeutically relevant marine natural products. Our goal is to share your contribution in a timely fashion and in a
manner that will be valued by the scientific community.

 

The journal Marine Drugs

The journal Marine Drugs (ISSN 1660-3397, IF 4.379) is currently running a special issue entitled "Marine Antiviral Agents". As Guest Editors for this issue, we hereby sincerely invite you to contribute a full research paper or a review to the special issue.

Special issue details
------------------------
*Topic* Marine Antiviral Agents
https://www.mdpi.com/journal/marinedrugs/special_issues/Marine_Antiviral_Agents

*Guest editor* Prof. Nathalie Bourgougnon Université de Bretagne Sud, France


*Submission Deadline* 11 November 2019
----------------------------

You may submit your manuscript now or up until the deadline. We would highly appreciate it if you could inform us in advance whether you are interested to make a contribution to the Special Issue.

As an open access journal (all published papers can be read or downloaded freely by readers), it increases publicity and promotes more frequent citations. Open access is supported by authors and their institutes. Article Processing Charges (APC) of 1800 CHF applies to all accepted papers (papers submitted after 31 December 2018 an APC of 2000 CHF applies.).

Each paper enjoys the advantage of our journal, including /High visibility/ and /Rapid publication/

High visibility: indexed by the Science Citation Index Expanded (Web of Science), MEDLINE (PubMed), Embase, Scopus, MarinLit and other databases. Full-text available in PubMed Central.

Rapid publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 17 days after submission; acceptance to publication is undertaken in 5.6 days (median values for papers published in the first six months of 2018).

 

Viral diseases, a worldwide problem

Despite the considerable progress made in recent years in virology, infectious human, animal, and plant viral diseases remain as worldwide problem. Effective controls and the treatments available for many infectious diseases are limited, and the need for new drugs is demonstrated, due to the increasing emergence of resistance to these available treatments. Knowledge of how to control viruses affecting aquaculture is scarce. The use and application of chemicals and antibiotics and their residual effects remain problematic.

 

Marine organisms represent a rich source of chemical diversity

Marine organisms (bacteria, fungi, seaweeds, invertebrates, etc.) represent a rich source of chemical diversity for the screening and identification of new compounds with antiviral properties. This Special Issue focuses on new information from present research on marine natural and synthetic compounds with antiviral potentials.

Special attention will be paid to innovative track explorations, the development of new biotechnology in aquaculture, the development of innovative antiviral probiotics, eco-friendly processes of extraction and purification, the relationship between structure and activity, and the synthesis of new marine antiviral compounds.